How to Survive a Biotech Blowup
Big biotech stocks were primed and ready to rip higher at the beginning of the fourth quarter. But, the market threw a wrench in our gears. Today, Greg Guenthner tells you why its time to cash out on biotech…
Big biotech stocks were primed and ready to rip higher at the beginning of the fourth quarter. But, the market threw a wrench in our gears. Today, Greg Guenthner tells you why its time to cash out on biotech…